Principles and guidance for developing lncRNA-targeted cancer therapies
By
Waleed H. Almalki
Crisp on the outside, thoughtful on the inside. A keeper.
Summary
This article discusses the emerging role of long non-coding RNAs (lncRNAs) as critical regulators in cancer biology, focusing on their potential as therapeutic targets. It outlines key principles and guidance for developing lncRNA-targeting cancer therapeutics, covering mechanisms of action, challenges in targeting these molecules, and strategic approaches for drug development. The content is technical and research-oriented, aimed at advancing cancer treatment through RNA-based therapeutics.
Key quotes
· 2 pulledlncRNAs have emerged as critical regulators of cellular identity and gene expression, with pervasive roles in cancer initiation, progression, and metastasis
Unlike PCG, lncRNAs function thr...
You might also wanna read
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·2h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·4h ago
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
A new experimental pill called daraxonrasib has shown promising results in extending survival for patients with advanced pancreatic cancer.
cnbc.com·5h ago
Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one
theguardian.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h ago
International trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients
bbc.co.uk·1d ago